CDCA4 and cancer: The subsequent survival analyses, which used patient data dichotomized for optimal cut off value in each cancer type (Figure 3B), demonstrate that survival differences in OS-related cancer types were all significant, indicating that patients with high CDCA4 expression had poorer outcomes (Figure 3B).